- Home
- NBTX vs ESSA Comparison
NBTX vs ESSA Comparison
Compare NBTX & ESSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- ESSA
- Stock Information
- Founded
- NBTX 2003
- ESSA 1916
- Country
- NBTX France
- ESSA United States
- Employees
- NBTX N/A
- ESSA N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- ESSA Banks
- Sector
- NBTX Health Care
- ESSA Finance
- Exchange
- NBTX Nasdaq
- ESSA Nasdaq
- Market Cap
- NBTX 201.9M
- ESSA 192.5M
- IPO Year
- NBTX 2020
- ESSA N/A
- Fundamental
- Price
- NBTX $3.83
- ESSA $20.15
- Analyst Decision
- NBTX Strong Buy
- ESSA
- Analyst Count
- NBTX 2
- ESSA 0
- Target Price
- NBTX $11.50
- ESSA N/A
- AVG Volume (30 Days)
- NBTX 8.8K
- ESSA 12.8K
- Earning Date
- NBTX 11-26-2024
- ESSA 10-23-2024
- Dividend Yield
- NBTX N/A
- ESSA 3.04%
- EPS Growth
- NBTX N/A
- ESSA N/A
- EPS
- NBTX N/A
- ESSA 1.81
- Revenue
- NBTX $45,220,186.00
- ESSA $68,480,000.00
- Revenue This Year
- NBTX N/A
- ESSA N/A
- Revenue Next Year
- NBTX N/A
- ESSA $6.92
- P/E Ratio
- NBTX N/A
- ESSA $11.10
- Revenue Growth
- NBTX 526.17
- ESSA N/A
- 52 Week Low
- NBTX $3.57
- ESSA $15.29
- 52 Week High
- NBTX $8.96
- ESSA $21.50
- Technical
- Relative Strength Index (RSI)
- NBTX 38.67
- ESSA 55.80
- Support Level
- NBTX $3.57
- ESSA $19.35
- Resistance Level
- NBTX $4.11
- ESSA $20.33
- Average True Range (ATR)
- NBTX 0.28
- ESSA 0.64
- MACD
- NBTX -0.00
- ESSA 0.01
- Stochastic Oscillator
- NBTX 26.31
- ESSA 52.46
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About ESSA ESSA Bancorp Inc.
ESSA Bancorp Inc is a holding company, engaged in accepting deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, in residential first mortgage loans (including construction mortgage loans), commercial real estate loans, home equity loans and lines of credit and commercial and industrial loans. The company offers a variety of deposit accounts, including checking, savings and certificates of deposit. The company also offers asset management and trust services and investment services. The company also offers insurance benefit consulting services through its wholly-owned subsidiary, ESSA Advisory Services, LLC.